SAENGER BRADLEY
SEC insider (Form 3/4/5 filer). CIK 0001668150. Chief Financial Officer at Tonix Pharmaceuticals Holding Corp. (TNXP). 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in BERKELEY HEIGHTS, NJ.
Companies SAENGER BRADLEY has filed insider reports for
- Tonix Pharmaceuticals Holding Corp. (TNXP): Officer, 10% Owner, Chief Financial Officer
SAENGER BRADLEY
CIK: 0001668150
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tonix Pharmaceuticals Holding Corp.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 30, 2026TNXP
Tonix Pharmaceuticals Holding Corp.
OtherDirect1.5K shares at avg. $10.91$16K - Feb 24, 2026TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
39K shares- - Feb 24, 2026TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
39K shares- - Dec 31, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirect701 shares at avg. $13.42$9K - Feb 25, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
25.8K shares- - Feb 25, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
25.8K shares- - Feb 5, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
OtherDirect0 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | Other | 1,453 | $10.91 | $15,858 | Direct |
| Feb 24, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | Award Stock Option | 39,012 | - | - | Direct |
| Feb 24, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | Award Stock Option | 39,011 | - | - | Direct |
| Dec 31, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Award | 701 | $13.42 | $9,407 | Direct |
| Feb 25, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Award Stock Option | 25,792 | - | - | Direct |
| Feb 25, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Award Stock Option | 25,792 | - | - | Direct |
| Feb 5, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Other | 0 | - | - | Direct |
1-7 of 7 transactions